Drug
aflibercept-ayyh
Marketed as PAVBLU.
Generic name
aflibercept-ayyh
Brand names
PAVBLU
First FDA approval
2024-08-23
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761298 | PAVBLU | 2024-08-23 | AMGEN INC |
Manufacturers
AMGEN INC
Frequently asked questions
When was aflibercept-ayyh FDA approved?
Earliest FDA approval on record: 2024-08-23.
What brand names are sold as aflibercept-ayyh?
PAVBLU.
Sources
Appeal a aflibercept-ayyh denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com